Literature DB >> 27582468

De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation.

Brian H Ladle1, Kun-Po Li2, Maggie J Phillips3, Alexandra B Pucsek3, Azeb Haile3, Jonathan D Powell3, Elizabeth M Jaffee3, David A Hildeman4, Christopher J Gamper3.   

Abstract

DNMT3a is a de novo DNA methyltransferase expressed robustly after T-cell activation that regulates plasticity of CD4(+) T-cell cytokine expression. Here we show that DNMT3a is critical for directing early CD8(+) T-cell effector and memory fate decisions. Whereas effector function of DNMT3a knockout T cells is normal, they develop more memory precursor and fewer terminal effector cells in a T-cell intrinsic manner compared with wild-type animals. Rather than increasing plasticity of differentiated effector CD8(+) T cells, loss of DNMT3a biases differentiation of early effector cells into memory precursor cells. This is attributed in part to ineffective repression of Tcf1 expression in knockout T cells, as DNMT3a localizes to the Tcf7 promoter and catalyzes its de novo methylation in early effector WT CD8(+) T cells. These data identify DNMT3a as a crucial regulator of CD8(+) early effector cell differentiation and effector versus memory fate decisions.

Entities:  

Keywords:  DNA methylation; T cells; cell differentiation; gene regulation; memory

Mesh:

Substances:

Year:  2016        PMID: 27582468      PMCID: PMC5035851          DOI: 10.1073/pnas.1524490113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets.

Authors:  Christian Stemberger; Katharina M Huster; Martina Koffler; Florian Anderl; Matthias Schiemann; Hermann Wagner; Dirk H Busch
Journal:  Immunity       Date:  2007-12       Impact factor: 31.745

2.  Global DNA methylation remodeling accompanies CD8 T cell effector function.

Authors:  Christopher D Scharer; Benjamin G Barwick; Benjamin A Youngblood; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

3.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection.

Authors:  Joshua J Obar; Kamal M Khanna; Leo Lefrançois
Journal:  Immunity       Date:  2008-05-22       Impact factor: 31.745

4.  Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation.

Authors:  Brendan E Russ; Moshe Olshanksy; Heather S Smallwood; Jasmine Li; Alice E Denton; Julia E Prier; Angus T Stock; Hayley A Croom; Jolie G Cullen; Michelle L T Nguyen; Stephanie Rowe; Matthew R Olson; David B Finkelstein; Anne Kelso; Paul G Thomas; Terry P Speed; Sudha Rao; Stephen J Turner
Journal:  Immunity       Date:  2014-11-06       Impact factor: 31.745

5.  A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet.

Authors:  Annie Xin; Frederick Masson; Yang Liao; Simon Preston; Tianxia Guan; Renee Gloury; Moshe Olshansky; Jian-Xin Lin; Peng Li; Terence P Speed; Gordon K Smyth; Matthias Ernst; Warren J Leonard; Marc Pellegrini; Susan M Kaech; Stephen L Nutt; Wei Shi; Gabrielle T Belz; Axel Kallies
Journal:  Nat Immunol       Date:  2016-03-07       Impact factor: 25.606

6.  Antigen processing in vivo and the elicitation of primary CTL responses.

Authors:  N P Restifo; I Bacík; K R Irvine; J W Yewdell; B J McCabe; R W Anderson; L C Eisenlohr; S A Rosenberg; J R Bennink
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

7.  Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation.

Authors:  Weiguo Cui; Nikhil S Joshi; Aimin Jiang; Susan M Kaech
Journal:  Vaccine       Date:  2009-02-06       Impact factor: 3.641

8.  Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.

Authors:  Rafael Guerrero-Preston; Christina Michailidi; Luigi Marchionni; Curtis R Pickering; Mitchell J Frederick; Jeffrey N Myers; Srinivasan Yegnasubramanian; Tal Hadar; Maartje G Noordhuis; Veronika Zizkova; Elana Fertig; Nishant Agrawal; William Westra; Wayne Koch; Joseph Califano; Victor E Velculescu; David Sidransky
Journal:  Epigenetics       Date:  2014-05-01       Impact factor: 4.528

9.  Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates.

Authors:  Surojit Sarkar; Vandana Kalia; W Nicholas Haining; Bogumila T Konieczny; Shruti Subramaniam; Rafi Ahmed
Journal:  J Exp Med       Date:  2008-03-03       Impact factor: 14.307

10.  Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses.

Authors:  Janilyn Arsenio; Boyko Kakaradov; Patrick J Metz; Stephanie H Kim; Gene W Yeo; John T Chang
Journal:  Nat Immunol       Date:  2014-03-02       Impact factor: 25.606

View more
  54 in total

Review 1.  Remembering to remember: T cell memory maintenance and plasticity.

Authors:  Kyla D Omilusik; Ananda W Goldrath
Journal:  Curr Opin Immunol       Date:  2019-06-03       Impact factor: 7.486

Review 2.  Regulation of T cell differentiation and function by epigenetic modification enzymes.

Authors:  Huicheng Liu; Pingfei Li; Zhengping Wei; Cai Zhang; Minghui Xia; Qiuyang Du; Yufei Chen; Na Liu; Huabin Li; Xiang-Ping Yang
Journal:  Semin Immunopathol       Date:  2019-04-08       Impact factor: 9.623

Review 3.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

Review 4.  Epigenetics of T cell aging.

Authors:  Jörg J Goronzy; Bin Hu; Chulwoo Kim; Rohit R Jadhav; Cornelia M Weyand
Journal:  J Leukoc Biol       Date:  2018-06-27       Impact factor: 4.962

Review 5.  Combining epigenetic and immune therapy to overcome cancer resistance.

Authors:  Stephanie Gomez; Tomasz Tabernacki; Julie Kobyra; Paige Roberts; Katherine B Chiappinelli
Journal:  Semin Cancer Biol       Date:  2019-12-23       Impact factor: 15.707

Review 6.  Metabolites, genome organization, and cellular differentiation gene programs.

Authors:  Danielle A Chisolm; Amy S Weinmann
Journal:  Curr Opin Immunol       Date:  2018-03-09       Impact factor: 7.486

Review 7.  Cancer Epigenetics, Tumor Immunity, and Immunotherapy.

Authors:  Jian Cao; Qin Yan
Journal:  Trends Cancer       Date:  2020-03-31

8.  CD8+ T Lymphocyte Self-Renewal during Effector Cell Determination.

Authors:  Wen-Hsuan W Lin; Simone A Nish; Bonnie Yen; Yen-Hua Chen; William C Adams; Radomir Kratchmarov; Nyanza J Rothman; Avinash Bhandoola; Hai-Hui Xue; Steven L Reiner
Journal:  Cell Rep       Date:  2016-11-08       Impact factor: 9.423

9.  The Loss of TET2 Promotes CD8+ T Cell Memory Differentiation.

Authors:  Shannon A Carty; Mercy Gohil; Lauren B Banks; Renee M Cotton; Matthew E Johnson; Erietta Stelekati; Andrew D Wells; E John Wherry; Gary A Koretzky; Martha S Jordan
Journal:  J Immunol       Date:  2017-11-17       Impact factor: 5.422

Review 10.  Circles of Life: linking metabolic and epigenetic cycles to immunity.

Authors:  Chan-Wang Jerry Lio; Stanley Ching-Cheng Huang
Journal:  Immunology       Date:  2020-06-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.